5-Isobutyl-3-methyl-2,4-imidazolidinedione(CAS: 675854-31-6)

5-Isobutyl-3-methyl-2,4-imidazolidinedione (CAS: 675854-31-6) must comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the European Union, and FDA/EPA requirements for chemical handling and disposal in the United States. It is classified as a skin and eye irritant under GHS, and manufacturers must provide appropriate safety data sheets (SDS).

While 5-Isobutyl-3-methyl-2,4-imidazolidinedione (CAS: 675854-31-6) is a widely used compound, alternatives include other imidazolidinediones and related heterocycles like 5-methyl-3-isobutyl-2,4-imidazolidinedione. These alternatives can provide similar functionalities in synthesis but may require different reagents and conditions.

The market for 5-Isobutyl-3-methyl-2,4-imidazolidinedione (CAS: 675854-31-6) is growing due to its applications in pharmaceuticals and agrochemicals. Research trends include its use as an intermediate in drug synthesis and as a biocide. Increasing demand from the pharmaceutical industry is driving market expansion.

Waste containing 5-Isobutyl-3-methyl-2,4-imidazolidinedione (CAS: 675854-31-6) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common method, but ensure it complies with local environmental regulations. Proper labeling and documentation are essential to ensure safe handling and disposal.